Influence of midluteal serum prolactin on outcome of pregnancy after IVF-ET: a preliminary study
Non-randomised trial
OA: closed
AI-generated summary
This prospective study of 29 IVF-ET patients found that lower midluteal serum prolactin levels and higher progesterone-to-prolactin ratios were associated with early pregnancy loss, suggesting these markers may predict IVF outcomes.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
PURPOSE: To investigate the relationship between serum prolactin levels in the midluteal phase and the prognosis of pregnancy after IVF-ET.
DESIGN: Prospective study;
SETTING: Shimane Medical University Hospital;
PATIENTS: 29 patients completing their 34th IVF cycle; and
MAIN OUTCOME MEASURES: Serum levels of prolactin, estradiol-17 beta, and progesterone in the midluteal phase.
RESULTS: Midluteal prolactin levels were significantly lower in patients with early pregnancy loss than in the successful pregnancy group. The mean progesterone/prolactin ratio and the estradiol-17 beta/prolactin ratio were highest in patients with early pregnancy loss and were lowest in patients with successful pregnancies.
CONCLUSIONS: Findings of this study suggest that measurement of the serum prolactin concentration in the midluteal phase is useful for predicting the outcome of IVF-ET.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-10-18T09:30:06.152893+00:00
- pubmed
- last seen: 2026-10-08T20:59:59.992071+00:00
- unpaywall
- last seen: 2026-10-21T06:41:41.500114+00:00